Amgen (AMGN) Interest Expenses (2009 - 2026)

Amgen (AMGN) has reported Interest Expenses for 18 consecutive years, with $657.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Expenses fell 9.13% year-over-year to $657.0 million; the TTM figure through Mar 2026 stood at $2.7 billion (down 11.95% YoY), while the FY2025 annual figure was $2.8 billion, down 12.68% from the prior year.
• Interest Expenses came in at $657.0 million for Q1 2026 at Amgen, up from $653.0 million in the prior quarter.
• The five-year high for Interest Expenses was $824.0 million in Q1 2024, with the low at $295.0 million in Q1 2022.
• Average Interest Expenses over 5 years is $638.1 million, with a median of $694.0 million recorded in 2025.
• Across the five-year window, Interest Expenses jumped 129.27% in 2023 and decreased 14.11% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $415.0 million in 2022, then jumped by 97.83% to $821.0 million in 2023, then slipped by 9.01% to $747.0 million in 2024, then fell by 12.58% to $653.0 million in 2025, then rose by 0.61% to $657.0 million in 2026.
• According to Business Quant data, Interest Expenses over the past three periods registered $657.0 million, $653.0 million, and $685.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.